Denali Therapeutics (NasdaqGS:DNLI) FY Conference Transcript

Denali Therapeutics (NasdaqGS:DNLI) FY Conference September 08, 2025 01:05 PM ET Company ParticipantsRyan Watts - Co-Founder, President, CEO & DirectorConference Call ParticipantsSean Laaman - Research Analyst - Biotechnology Small & MidcapSean LaamanAnd everyone, and welcome to Morgan Stanley Global Healthcare Conference. I'm Sean Norman, Head of US MidCap Biotech Equity Research at the firm. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/resea ...